COM:ALKEUSPHARMA
Alkeus Pharmaceuticals Inc
- Privately Held
Description
Alkeus Pharmaceuticals Inc develops Gildeuretinol (ALK-001), an investigational therapy aimed at addressing the underlying mechanism of Stargardt disease, a genetic cause of blindness.